Option Care gets 75% of its revenues from chronic therapies and 25% from acute treatments, but its growth now looks ...

Initiation of Phase 1b study using SGT-212 for the treatment of patients with Friedreich's Ataxia expected in 2H25. Click ...

The compound can then be delivered through injection, infusion ... reaching more treatment centres and patients,” Taylor outlined. Clarity announced in August that its phase 1/2a trial in ...

On the third day, drugmakers provided updates on precision medicines for cancer and Alzheimer's, and Grail talked about the launch of a new version of the Galleri test.

RESULTS Seventy nine patients were identified (seven dead, 72 transplanted). Two patients (2.5%) were heterozygous for the Z allele of α 1-AT and four (5.1%) were heterozygous for the S allele. This ...

Alpha-gal syndrome is usually thought of as red meat allergy, but the tick-caused ailment can also spur allergies to ...

How to Choose the Best Hair Loss Treatment for You Finding the right hair loss treatment depends on the type and severity of your hair loss. With so many options available, it’s important to ...

I’ve had four infections in my lymphedema arm with five treatment infusions, therefore needing antibiotics immediately ... communication and I’ll take bookings for any member to have 1-2-1 chats with ...

A stock with a beta of 1.5 is a high beta and could return 15%. As noted earlier, alpha measures the value a manager adds to a portfolio when adjusting for risk and market returns. It's usually ...

Treatment for allergic or irritant contact dermatitis ... You usually take them for 1 to 2 weeks. If you require them for longer, you may first need to stop using them for at least 2 to 4 weeks ...

Maia Beth presents the future of pop music with a Future Bop from Chloe Qisha. Chappell Roan - exclusive Sound of 2025 interview Chappell Roan reflects on the last 12 months in an extensive chat ...

The problem for Lilly’s sintilimab application is that there already exist a number of approved PD-1 treatments on the US market, making it difficult to suggest that the treatment represented an ...